Press release
Glaucoma Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Glaucoma Overview
Glaucoma is a condition of increased intraocular pressure in the eye that may progress to a loss of vision. This results in a characteristic optic nerve head appearance on fundoscopic examination and a corresponding progressive loss of vision. Because it may be asymptomatic until a relatively late stage, diagnosis is frequently delayed.
"Glaucoma Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Glaucoma Market.
The Glaucoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Glaucoma Pipeline Report: https://www.delveinsight.com/report-store/glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Glaucoma treatment therapies with a considerable amount of success over the years. Glaucoma Key players such as - Q BioMed, InMed Pharmaceuticals, ONL Therapeutics, Mitotech, TheratOcular Biotek Co., Ltd., AbbVie, JeniVision, Qlaris Bio, AbbVie V, Nicox, Tarsier Pharma Ltd, Santen Pharmaceutical, and others, are developing therapies for the Glaucoma treatment
• Glaucoma Emerging therapies such as - MAN-01, INM-088, ONL 1204, Visomitin, TO-O-1001, AGN-193408, JV-GL1, QLS-101, AGN-193408, NCX 470, TRS01, STN-1012600, and others are expected to have a significant impact on the Glaucoma market in the coming years.
• In November 2020, Nicox initiated a 3-month Phase III trial evaluating the safety and efficacy of NCX 470ophthalmic solution, 0.1%, versus the current standard of care, latanoprost ophthalmic solution, 0.005%, for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension
Glaucoma Pipeline Therapeutics Assessment
• Glaucoma Assessment by Product Type
• Glaucoma By Stage and Product Type
• Glaucoma Assessment by Route of Administration
• Glaucoma By Stage and Route of Administration
• Glaucoma Assessment by Molecule Type
• Glaucoma by Stage and Molecule Type
DelveInsight's Glaucoma Report covers around 70+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Emerging Glaucoma Drugs Under Different Phases of Clinical Development Include:
• MAN-01: Q BioMed
• INM-088: InMed Pharmaceuticals
• ONL 1204: ONL Therapeutics
• Visomitin: Mitotech
• TO-O-1001: TheratOcular Biotek Co., Ltd.
• AGN-193408: AbbVie
• JV-GL1: JeniVision
• QLS-101: Qlaris Bio
• AGN-193408: AbbVie V
• NCX 470: Nicox
• TRS01: Tarsier Pharma Ltd
• STN-1012600: Santen Pharmaceutical
Get a Free Sample PDF Report to know more about Glaucoma Pipeline Assessment- https://www.delveinsight.com/report-store/glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Glaucoma Pipeline Analysis:
The Glaucoma pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the Glaucoma treatment with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Glaucoma Treatment.
• Glaucoma key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Glaucoma Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Glaucoma market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Glaucoma product details are provided in the report. Download the Glaucoma pipeline report to learn more about the emerging Glaucoma therapies at:
https://www.delveinsight.com/report-store/glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Glaucoma Pipeline Market Drivers
• Growing Prevalence of glaucoma
• Development of novel therapies
• Growing awareness due to government initiatives and pharmaceutical companies
Glaucoma Pipeline Market Barriers
• High medical cost
• Side-effects associated with the drugs
Scope of Glaucoma Pipeline Drug Insight
• Coverage: Global
• Key Glaucoma Companies: Q BioMed, InMed Pharmaceuticals, ONL Therapeutics, Mitotech, TheratOcular Biotek Co., Ltd., AbbVie, JeniVision, Qlaris Bio, AbbVie V, Nicox, Tarsier Pharma Ltd, Santen Pharmaceutical, and others
• Key Glaucoma Therapies: MAN-01, INM-088, ONL 1204, Visomitin, TO-O-1001, AGN-193408, JV-GL1, QLS-101, AGN-193408, NCX 470, TRS01, STN-1012600, and others
• Glaucoma Therapeutic Assessment: Glaucoma current marketed and Glaucoma emerging therapies
• Glaucoma Market Dynamics: Glaucoma market drivers and Glaucoma market barriers
Request for Sample PDF Report for Glaucoma Pipeline Assessment and clinical trials- https://www.delveinsight.com/report-store/glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Glaucoma Report Introduction
2 Glaucoma Executive Summary
3 Glaucoma Overview
4 Glaucoma- Analytical Perspective In-depth Commercial Assessment
5 Glaucoma Pipeline Therapeutics
6 Glaucoma Late Stage Products (Phase II/III)
7 Glaucoma Mid Stage Products (Phase II)
8 Glaucoma Early Stage Products (Phase I)
9 Glaucoma Preclinical Stage Products
10 Glaucoma Therapeutics Assessment
11 Glaucoma Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Glaucoma Key Companies
14 Glaucoma Key Products
15 Glaucoma Unmet Needs
16 Glaucoma Market Drivers and Barriers
17 Glaucoma Future Perspectives and Conclusion
18 Glaucoma Analyst Views
19 Appendix
20 About DelveInsight
Download Sample PDF Report to know more about Glaucoma drugs and therapies- https://www.delveinsight.com/report-store/glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
Glaucoma Market https://www.delveinsight.com/report-store/glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Glaucoma-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Glaucoma Epidemiology https://www.delveinsight.com/report-store/glaucoma-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Glaucoma Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Ventricular Assist Devices (VAD) Market Insight, Competitive Landscape and Market Forecast - 2027' report delivers an in-depth understanding of Ventricular Assist Devices and the historical and forecasted Ventricular Assist Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Basal Cell Carcinoma (Basal Cell Epithelioma) Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma), historical and forecasted epidemiology as well as the Basal Cell Carcinoma (Basal Cell Epithelioma) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glaucoma Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2774105 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Glaucoma
Glaucoma Surgery Devices Market Report 2024 - Glaucoma Surgery Devices Market Si …
"The Business Research Company recently released a comprehensive report on the Global Glaucoma Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The glaucoma surgery devices…
Global Glaucoma Market
According to a new market research report published by Global Market Estimates, the Global Glaucoma Market is projected to grow at a CAGR value of 5.0% from 2023 to 2028.
Growing awareness for early diagnosis of glaucoma have gained prominence due to various educational campaigns and screening programs. Early detection allows for timely intervention, leading to better disease management and reducing the risk of vision loss, thus propelling the market growth.…
Glaucoma Treatment Market - Safeguarding Sight: Innovating Glaucoma Treatment fo …
Newark, New Castle, USA: The "Glaucoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Glaucoma Treatment Market: https://www.growthplusreports.com/report/glaucoma-treatment-market/8926
This latest report researches the industry structure, sales, revenue,…
Glaucoma Surgical Devices Market By Device Type (Glaucoma Drainage Devices, Impl …
Glaucoma Surgical Devices market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain…
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the…
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide.
Sudden increase in the aging population and…
